Evidence map›Paper›PMID 26677227›Full record

ArticleThe Journal of biological chemistry2016

Ras Regulates Rb via NORE1A.

Thibaut Barnoud, Howard Donninger, Geoffrey J Clark

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Tumor suppressor C-RASSF proteins.Cellular and molecular life sciences : CMLS · 2018
    Review
  11. Intrinsic protein disorder in oncogenic KRAS signaling.Cellular and molecular life sciences : CMLS · 2017
    Review
  12. Review
  13. Article
  14. Ras signaling through RASSF proteins.Seminars in cell & developmental biology · 2016
    Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Thibaut BarnoudFrom the Departments of Biochemistry and Molecular Genetics.
Howard DonningerMedicine, and.
Geoffrey J ClarkPharmacology and Toxicology, James Graham Brown Cancer Center, Molecular Targets Program, University of Louisville, Louisville, Kentucky 40202 gjclar01@louisville.edu.
Laboratory of Molecular Genetics · PLUniversity of Louisville · US

Funding

The role of the Ras effector Nore1a in tumor suppressionR01CA133171 · NCI · UNIVERSITY OF LOUISVILLE · PI CLARK, GEOFFREY J. · 2010 to 2014
$1.3M
NCI NIH HHS R01 CA133171NCI NIH HHS R01 CA133171-01A2
6 · The paper itself

Abstract

Mutations in the Ras oncogene are one of the most frequent events in human cancer. Although Ras regulates numerous growth-promoting pathways to drive transformation, it can paradoxically promote an irreversible cell cycle arrest known as oncogene-induced senescence. Although senescence has clearly been implicated as a major defense mechanism against tumorigenesis, the mechanisms by which Ras can promote such a senescent phenotype remain poorly defined. We have shown recently that the Ras death effector NORE1A plays a critical role in promoting Ras-induced senescence and connects Ras to the regulation of the p53 tumor suppressor. We now show that NORE1A also connects Ras to the regulation of a second major prosenescent tumor suppressor, the retinoblastoma (Rb) protein. We show that Ras induces the formation of a complex between NORE1A and the phosphatase PP1A, promoting the activation of the Rb tumor suppressor by dephosphorylation. Furthermore, suppression of Rb reduces NORE1A senescence activity. These results, together with our previous findings, suggest that NORE1A acts as a critical tumor suppressor node, linking Ras to both the p53 and the Rb pathways to drive senescence.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsApoptosis Regulatory ProteinsCellular SenescenceChlorocebus aethiopsCOS CellsHEK293 CellsHep G2 CellsHumansMonomeric GTP-Binding ProteinsPhosphorylationProtein Phosphatase 1Proto-Oncogene Proteins p21(ras)Retinoblastoma ProteinTumor Suppressor Protein p53Adaptor Proteins, Signal TransducingApoptosis Regulatory ProteinsHRAS protein, humanKRAS protein, humanMonomeric GTP-Binding ProteinsProtein Phosphatase 1Proto-Oncogene Proteins p21(ras)RASSF5 protein, humanRetinoblastoma ProteinTP53 protein, humanTumor Suppressor Protein p53cancercellular senescenceNORE1Aprotein phosphorylationRas proteinRASSFretinoblastoma protein (pRb, RB)

Identifiers

PMID26677227
PMCPMC4742771
OpenAlexW2269064503

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.